Disease-associated Reprogramming
Disease-Associated Reprogramming is a molecular reprogramming strategy that redirects cellular identity in the context of pathological states, distinguished by its targeted modulation of disease-specific epigenetic or transcriptional networks to restore normal function or model disease mechanisms.
5
Publications
161
Citations
47
Authors
22
Institutions
Publications per year
2017–2026
4
Parents
5
Federica Raggi, Davide Cangelosi, Pamela Becherini et al. · Journal of Translational Medicine · 2020 · 17 citations · Full text
Medicine, Bioinformatics, Cardiology +15
1–5 of 5
47
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 47
22
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Badalona, Spain
1 h-index
8 publications
304 citations
Université Paris-Est Créteil
Créteil, France
1 h-index
1 publications
17 citations
Altos Labs
San Francisco, United States
1 h-index
2 publications
106 citations
Institut Català d'Oncologia
Barcelona, Spain
1 h-index
1 publications
38 citations
IRCCS Ospedale San Raffaele
Milan, Italy
1 h-index
1 publications
17 citations
Institució Catalana de Recerca i Estudis Avançats
Barcelona, Spain
1 h-index
1 publications
38 citations
Istituto Giannina Gaslini
Genoa, Italy
1 h-index
12 publications
204 citations
University of California, Los Angeles
Los Angeles, United States
1 h-index
2 publications
106 citations
1–8 of 22
1 publications · 13 citations
1
h-index
1 publications · 40 citations
1
h-index
JTM · 1 publications · 17 citations
1
h-index
1 publications · 38 citations
1
h-index
1 publications · 53 citations
1
h-index
1–5